Introduction
In the 1950s there was concern about the high level of morbidity and mortality from chronic bronchitis in Britain; between 1957 and 1961 the death rate from bronchitis was 108/100 000 in men aged 45-64 in England, Wales, and Scotland, which was about 20 times the rate in Denmark and Norway.' Within the United Kingdom pronounced variations in mortality were recorded, higher rates being found in urban areas and the lower social classes.2 One study undertaken at that time to discover the reason for these variations was a survey of respiratory symptoms in a random sample of men and women attending general medical practices in Britain. 4 The questionnaire developed for that survey subsequently served as the basis for the Medical Research Council's questionnaire on respiratory symptoms, which is widely used today. The people who were surveyed in 1958 by using the original questionnaire have been followed up to the end of 1985. We describe the associations between their reported respiratory symptoms and their subsequent death rates.
Subjects and methods
Details of the original survey have been reported.4 Briefly, the sample consisted of adult men and women chosen at random from the lists of general practitioners in rural and urban areas of England, Wales, and Scotland. Stratified random samples of one man and one woman in each of the five year age groups 40-44, 45-49, 50-54, 55-59, and 60-64 were drawn from each participating practice. Each practice undertook to interview at least one such sample of 10 subjects. If a sampled subject had died or moved a substitute of the same sex was selected at random from the appropriate age group. Of the 1630 people thus sampled and available for examination at the time of the survey in 1958, 1569 (96%) were interviewed. Data relating to 442 wives of sampled men, which were presented in the original report, are not included here because they did not form a representative sample of women in the population.
The questionnaire used in the survey subsequently served as the prototype for the Medical Research Council's questionnaire on respiratory symptoms, though it underwent some revisions in 1966, 1976 , and 1986.6 During this process some of the original questions were omitted, others were modified, and a few were retained essentially unchanged. For example, the questions on cough and phlegm in winter (see appendix) bear a close relation to those in the 1976 and 1986 questionnaires. The original questionnaire provided for five categories of severity of breathlessness, two more than commonly used today (appendix). The additional questions were, Do you have to stop for breath after walking about 100 yards [90 m] (or after a few minutes) on the level? and Are you too breathless to leave the house or breathless on undressing? Wheeze was also more finely categorised (into three grades) than in more recent questionnaires-namely, as wheeze with colds only, occasional wheeze, and wheeze most days or nights.
Because of their relevance to studies using later versions of the questionnaire the questions on cough, phlegm, breathlessness, and wheeze listed in the appendix form the core group of symptoms for analysis in this report. Analyses of data relating to three additional questions on symptoms which were not included in subsequent questionnaires are also reported. These were, Does the weather affect your chest? Is your breathing different in summer and winter? and If you get a cold does it usually go to your chest?
In the original report a "standard diagnosis" of bronchitis was defined as a combination of morning phlegm in winter, bouts of cough and phlegm lasting three weeks each winter, and breathlessness when walking on the level (breathlessness category II or higher). 4 People who reported all of these symptoms were identified to assess the ability of this definition of bronchitis to predict subsequent mortality.
In addition to respiratory symptoms, data were obtained at interview on social class (registrar general's classification7) and smoking habits. Subjects were categorised as non-smokers, ex-smokers, or current smokers. For ex-smokers the age at starting and stopping regular cigarette smoking was recorded, and for current smokers the age at starting smoking and number of cigarettes smoked daily were recorded.
Identifying data on all subjects interviewed were subsequently sent to the NHS's central register at Southport, and for each death notified a copy of the death certificate was obtained. Person years at risk were computed from the date of interview to the end of 1985 or, if death had occurred, to the date of death. The underlying cause of death was coded by using the 8th revision of the International Classification of Diseases. Deaths from all causes (ICD codes 000-999) and from chronic bronchitis (including emphysema) (ICD 490-492, 519), cardiovascular disease (ICD 400-453), and lung cancer (ICD 162) were investigated.
The mortality among subjects reporting a particular symptom (or combination of symptoms) was compared with that among subjects not reporting that symptom and expressed as a mortality ratio; a ratio of 1 0 implied no difference in mortality between the two groups. Death rates were estimated by using deaths and person years at risk observed in the cohort during the 27 years of follow up. For most of the analyses deaths and person years at risk were cross classified according to age at interview (five groups: 40-44, 45-49, 50-54, 55-59, 60-64), sex, smoking state (non-smoker, ex-smoker, current smoker), and response to each question on symptoms. Mortality ratios adjusted for age, sex, and smoking were estimated from these data by the method of maximum likelihood using the generalised linear interactive modelling (GLIM) computer package' as described by Breslow and Day. 9 In further analyses of mortality from chronic bronchitis mortality ratios were estimated separately for three follow up periods-namely 0-4, 5-9, and 10 or more years after the date of interview. Additional adjustment for social class (as groups I, II, III, IV, and V) was performed in some analyses, and two alternative classifications of smoking habit were also examinednamely, current amount smoked (five groups: nonsmokers, ex-smokers, current smokers of 0-9, 10-19, or 20 or more cigarettes a day) and years of smoking (five groups: non-smokers, ex-smokers who had smoked for less than 30 years or 30 years or more, and current smokers who had smoked for less than 30 years or 30 years or more).
Thirty subjects who had either emigrated or could not be traced at the NHS's central register were excluded from the analyses. One woman was excluded because she had a permanent tracheostomy tube. A further five men and one woman were excluded because their dates of birth were not known. This report therefore relates to 1532 subjects (768 men, 764 women)-that is, 98% of the original sample interviewed. Fourteen men and 21 women who were disabled at the time of interview were excluded from analyses of questions on breathlessness.
Results Table I gives the prevalence at interview of the symptoms analysed. Response rates for the different questions were high. Wheeze and morning cough were the most commonly reported symptoms in men, with prevalences of 49% and 47% respectively. The prevalence of cough and phlegm was substantially lower in women than men but there was less difference in the prevalence of other symptoms. Breathlessness and wheeze were the commonest of the core group of respiratory symptoms in women, with prevalences of 42% and 36% respectively. "Cold usually goes to chest" was the additional respiratory symptom most commonly reported, the prevalence being about 40% in men and women. Smoking was particularly common in men, three quarters of whom were current smokers.
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Breathlessnesst: Fourteen deaths from chronic bronchitis in men occurred in the first five years, nine between five and 10 years, and 28 more than 10 years after the date of interview. Eleven of the 14 deaths in the first five years occurred in men who met the criteria for a standard diagnosis, and the mortality ratio was particularly high (31-0; 95% confidence interval, to 114-5). Mortality ratios during this period were also high for day or night cough (14 7; 4-1 to 53-0), day phlegm (18 0; 5 0 to 65 0), and wheeze (category III; 26 4 , 3 2 to 218 1). Ratios could not be estimated for breathlessness during this period because there were no deaths among non-breathless men. During the second five years of follow up mortality ratios were generally much lower. At 10 or more years after the initial symptom report, however, all symptoms examined continued to be associated with excess mortality from chronic bronchitis. Mortality ratios during this period were highest for persistent wheeze (category III; mortality ratio 4-9, 1-6 to 14 9), breathlessness (category II; 3 8, 1-4 to 10-6), and "weather affects chest" (3-8, 1-8 to 8-0). As in analyses of data for the whole follow up period (table II) , mortality ratios for wheeze and breathlessness increased with the severity of symptoms during this period of follow up.
As three quarters of the men who were interviewed were smokers, it was important to examine the effect of adjusting for smoking as measured by amount smoked or number of years of smoking as opposed to the three categories of smoking (non-, ex-, current) used above. When mortality from chronic bronchitis in men was analysed after adjustment for either amount smoked daily or number of years of smoking mortality ratio estimates as presented in table II changed very little (not shown). Adjustment for social class in addition to age and smoking tended to diminish mortality ratios for bronchitis, but only slightly. For example, the mortality ratio for category II breathlessness was 5-7 (95% confidence interval, 2 6 to 12 5).
Mortality ratios for chronic bronchitis were also adjusted for phlegm (defined as report of either morning or day phlegm) or breathlessness, or both, to Coldusually goestochest [3] [4] [5] [6] (1-9to6-7)
*Fourteen men who were disabled were excluded from all analvscs sf all questions.
tPhlegm assessed as report of either morning phlegm or day phlegm versus rcport of neither.
assess the additional contribution made by other symptoms in predicting mortality (table III) . Adjustment for phlegm or breathlessness (by using categories I, II, and III-V) reduced mortality ratios for all symptoms, the reductions being slightly greater after adjustment for breathlessness. When adjustment was made for both phlegm and breathlessness mortality ratios for cough and bouts of cough and phlegm were no longer raised significantly, whereas those for wheeze and "weather affects chest" remained significantly above unity. When adjustment was made for breathlessness and wheeze mortality ratios for morning phlegm and day phlegm were 1-6 (95% confidence interval, 0 8 to 3 2) and 2-3 (1P2 to respectively. Finally, analyses were performed restricting data to men who had reported no breathlessness at interview. Mortality ratios for chronic bronchitis for each of the symptoms were generally lower and not significant in this subgroup. Only that for occasional wheeze (category II) was raised significantly (mortality ratio 3 7; 95% confidence interval, 1 -2 to 11 6).
Discussion
The general practitioners who took part in this survey consisted of 92 members of the (then) College of General Practitioners who agreed to participate.4 Though the resulting sample of subjects was therefore not strictly random, marital state and social class distributions were very similar to those of people in the same age groups in England and Wales in 195 14 and 196 1. '°" Sex specific prevalences of smoking in this sample were also in line with published data for the age group and period examined.'2 Certainly in these respects the sample seemed to be representative of the general population at that time.
Follow up was performed by using the routine system for reporting mortality in the United Kingdom and, though possibly some deaths may have been missed, mortality ratios would be biased only if, for example, deaths in people with symptoms were more likely to be reported to the NHS's central register. This type of bias, however, is perhaps less relevant when assessing the relative importance of different respiratory symptoms as predictors of mortality.
MORTALITY FROM ALL CAUSES, CARDIOVASCULAR DISEASE, AND LUNG CANCER
The association of mortality from all causes and cardiovascular disease and a report of breathlessness found in our series is consistent with other studies. Ferris et al found excess mortality from all causes to be associated with breathlessness in men and women. " Though many of the respiratory symptoms that we examined seemed less predictive of subsequent all cause mortality in women than men, reported breathlessness and wheeze were more alike in their ability to predict all cause mortality in the two sexes. Higgins and Keller found breathlessness to be the symptom with highest predictive power for four year mortality in Tecumseh, particularly from coronary heart disease. '4 More recently breathlessness, but not production of phlegm, was consistently associated with mortality from cardiovascular disease independently of several other coronary risk factors in data from four prospective studies of men. '5 In another study breathlessness was independently associated with an increased risk of a major ischaemic heart disease event in men with no evidence of pre-existing cardiac disease. ' 
Conclusion
The standard diagnosis of bronchitis adopted in the College of General Practitioners' study reflected the thinking of that time in considering production of phlegm and exertional breathlessness to be symptoms of the same disease. This is no longer thought to be appropriate. 34 
